The role of surgery in weaning patients from home parenteral support - A cohort study.

Abstract

Some patients with intestinal failure requiring home parenteral support (HPS) may be weaned. This study considered all abdominal surgery in a cohort of HPS patients over a 25-year period. Our aim was to identify how many patients can be weaned from HPS and by what means, and to identify what makes weaning more likely. A prospectively collected database of HPS patients to December 2018 was analysed for outcomes of care. At 5years 56% of 205 patients remained on HPS. Fifty eight patients (28%), who had 68 operations, stopped HPS after surgery. Patients stopping HPS had a longer median final small bowel length (155cm, range 45-350cm) and were more likely to have colon in circuit (84%) than patients who had reconstructive surgery but did not stop HPS (median small bowel length 50cm, range 15-135cm; 50% colon in circuit). The median period between HPS discharge and reconstructive surgery was 238days. There were no deaths, but 18 Clavien-Dindo grade 3-4 complications occurred within 30days. Ninety per cent of patients who stopped HPS survived for 5years from the start of HPS in comparison with 53% of those who remained on HPS. No previous study has examined surgery in an entire cohort of HPS patients. More than a quarter of HPS patients can be weaned after reconstructive surgery. The length of bowel available for recruitment at surgery is the main determinant of the ability to stop HPS. The possibility of reconstruction should be considered, since patients who stop HPS appear to have a survival advantage.